Page last updated: 2024-11-02

phenylmethylsulfonyl fluoride and Chronic Illness

phenylmethylsulfonyl fluoride has been researched along with Chronic Illness in 1 studies

Phenylmethylsulfonyl Fluoride: An enzyme inhibitor that inactivates IRC-50 arvin, subtilisin, and the fatty acid synthetase complex.
phenylmethanesulfonyl fluoride : An acyl fluoride with phenylmethanesulfonyl as the acyl group.

Research Excerpts

ExcerptRelevanceReference
"Periodontitis is characterized by extensive destruction of the gingival tissues and associated supporting structures of the teeth."1.31Analysis of in situ protease activity in chronic adult periodontitis patients: expression of activated MMP-2 and a 40 kDa serine protease. ( Billings, PC; Feldman, RS; Korostoff, JM; Sarment, DP; Stewart, JC; Wang, JF, 2000)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Korostoff, JM1
Wang, JF1
Sarment, DP1
Stewart, JC1
Feldman, RS1
Billings, PC1

Other Studies

1 other study available for phenylmethylsulfonyl fluoride and Chronic Illness

ArticleYear
Analysis of in situ protease activity in chronic adult periodontitis patients: expression of activated MMP-2 and a 40 kDa serine protease.
    Journal of periodontology, 2000, Volume: 71, Issue:3

    Topics: Adult; Anti-Bacterial Agents; Blotting, Western; Chronic Disease; Cohort Studies; Electrophoresis, P

2000